Results 121 to 130 of about 31,753 (281)

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

Differential Impact of Metabolic Bariatric Surgery Versus Semaglutide on Adverse Hepatic and Extrahepatic Outcomes in Individuals With Metabolic Dysfunction‐Associated Steatotic Liver Disease and Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim We compared the impact of metabolic bariatric surgery (MBS) versus semaglutide on clinical outcomes in individuals with metabolic dysfunction‐associated steatotic liver disease (MASLD) and type 2 diabetes (T2D). Methods Patients with MASLD and T2D who had MBS or semaglutide in 2018–2023 were identified (TriNetX database).
Weronika Stupalkowska, Alex E. Henney, David R. Riley, Eric G. Sheu, Uazman Alam, Daniel J. Cuthbertson   +5 more
wiley   +1 more source

Pro-tobacco marketing and anti-tobacco campaigns aimed at vulnerable populations: A review of the literature. [PDF]

, 2019
INTRODUCTION:We reviewed research literature on pro-tobacco marketing and anti-tobacco campaigns targeting eight vulnerable populations to determine key findings and research gaps.
Baezconde-Garbanati, Lourdes, Byron, M Justin, Carroll, Dana M, Cruz, Tess Boley, Huang, Li-Ling, Lienemann, Brianna A, Meissner, Helen I, Rose, Shyanika W, Soto, Claradina, Unger, Jennifer B   +9 more
core  

Is the use of tobacco products, especially electronic nicotine delivery systems (ENDS), associated with the incidence of oral health outcomes among US adults? [PDF]

, 2023
C. A. Yeung
openalex   +1 more source

GLP‐1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity‐Matched Real‐World Analysis

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Evidence on cardiovascular/renal outcomes associated with GLP‐1‐based therapies in type 1 diabetes (T1D) is limited. We examined the effects of GLP‐1‐based therapy on major clinical outcomes and safety, including diabetic ketoacidosis (DKA) and hypoglycemia risk, in adults with T1D in a large real‐world cohort.
Anastasios Tentolouris, Charalampos Filippatos, Nikolaos‐Iason Tepetes, Maria Gavriatopoulou, Evangelos Terpos, Alexandros Briasoulis, Kimon Stamatelopoulos, Theodosios Filippatos   +7 more
wiley   +1 more source

Identifying misleading propaganda of Electronic Nicotine Delivery Systems (ENDS) and hookah in New Delhi, India: building youth self-efficacy skills to resist new industry tactics

Tobacco Induced Diseases, 2018
Background and challenges to implementation The Indian tobacco control law (COTPA) prohibits tobacco advertising, promotion and sponsorship. However, emerging products like e-cigarettes and e-hookahs (ENDS) remain unregulated and traditional hookahs are ...
Prachi Kathuria, Radhika Shrivastav, Monika Arora, Praveen Sinha, Vineet Gill Munish, Fikru Tullu   +5 more
doaj   +1 more source

Conventional cigarettes, novel heated tobacco products, and self‐reported frequent headache association in Japanese individuals: Insights from the JASTIS study, a Japanese cross‐sectional analysis

Headache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary Headache is a common health problem, and tobacco products, such as conventional cigarettes and heated tobacco products (HTPs), may be associated with it. Using data from over 23,000 adults in the Japan Society and New Tobacco Internet Survey, we examined the relationships between cigarette and HTP use and self‐reported frequent ...
Masahito Katsuki, Kieran Moran, Muneto Tatsumoto, Keisuke Suzuki, Tomokazu Shimazu, Yasuhiko Matsumori, Yutaro Fuse, Miguel Á. Huerta, Daijiro Sugiyama, Jackson T. S. Cheung, Siobhán O'Connor, Tomás Ward, Takahiro Tabuchi   +12 more
wiley   +1 more source

Are electronic nicotine delivery systems an effective smoking cessation tool?

Canadian Journal of Respiratory Therapy, 2015
Despite the known adverse effects of smoking, including lung cancer and other respiratory diseases, a significant proportion of the Canadian population continue to smoke.
Christine Lam, Andrew West
doaj  

Nicotine delivery from the refill liquid to the aerosol via high-power e-cigarette device

Scientific Reports, 2017
To offer an enhanced and well-controlled nicotine delivery from the refill liquid to the aerosol is a key point to adequately satisfy nicotine cravings using electronic nicotine delivery systems (ENDS). A recent high-power ENDS, exhibiting higher aerosol
Nathalie Prévôt, Fabien de Oliveira, Sophie Perinel-Ragey, Thierry Basset, Jean-Michel Vergnon, Jérémie Pourchez   +5 more
doaj   +1 more source

Consumers’ Preferences for Electronic Nicotine Delivery System Product Features: A Structured Content Analysis [PDF]

, 2017
Christine E. Kistler, Trisha M. Crutchfield, Erin L. Sutfin, Leah M. Ranney, Micah L. Berman, Gary A. Zarkin, Adam O. Goldstein   +6 more
openalex   +1 more source